• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Susan Urba, MD, Discusses Treatments for CINV

Article

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Susan Urba, MD, Medical Director, Symptom Management & Supportive Care Program, University of Michigan, says that preventative medications given prior to treatment are necessary in order to improve the quality of life for patients with chemotherapy-induced nausea and vomiting (CINV).

Dr Urba says that vomiting is well controlled, but nausea is still a problem despite the preventative medication. "For now, prevention is the key," Dr Urba said. "Giving the adequate drugs for the category that the patient is in, and hopefully the patient's quality of life will improve."

Related Videos
Dr Ola Landgren
David Awad, PharmD, BCOP
Gordon Crofoot, MD, PA
Jaime Almandoz, MD, MBA
Screenshot of Coral Omene, MD, PhD
Dr Brian Slomovitz
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Adam Colborn, JD, associate vice president for congressional affairs, Academy of Managed Care Pharmacy (AMCP)
ASCO 2025
H. John Beardsley, MBA, and Fauzea Hussain, MPH, sitting for a video interview
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.